RNA Interference (RNAi) Nucleic Acid Therapeutics Market Size, Opportunities, Key Drivers and Competitive Outlook RNA Interference (RNAi) Nucleic Acid Therapeutics Market Segmentation, By Type (Small Interfering RNA (siRNA), MicroRNA (miRNA)), Route of Administration (Intravenous, Intradermal, Pulmonary Delivery, Intrathecal, and Others), Indication (Acute Hepatic Porphyria (AHP), Hereditary Transthyretin-Mediated Amyloidosis (hATTR), Hypercholesterolemia, and Others), End User (Hospitals &...
0 Compartilhamentos
27 Visualizações